Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Eltrombopag

Brand: RevoladeĀ®
NICE TA: 382
Indication: Treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal NICE TA382)
Disease category: Nutrition and blood
Commissioning responsibility: CCG
PbR excluded: 

Background

NICE is unable to make a recommendation about the use in the NHS of eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy because no evidence submission was received from Novartis for the technology.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Black

Black

Black

Black

Black

Black